FELDMANN CYNTHIA L sold $287K of UFPT

FELDMANN CYNTHIA L sold 1,200 shares of UFP TECHNOLOGIES INC (UFPT) at an average of $239.29 ($239.19–$240.40, $0.29M total) across 2 trades on 2026-06-12.

Original reporting
SEC EDGAR · FELDMANN CYNTHIA L
Published Jun 15, 2026, 3:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 3:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UFPT
Neutral
medium confidence
Mentioned
$UFPT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UFPTNeutralLow
01

Why it matters

A director’s open-market sale can slightly pressure sentiment, but there is no accompanying guidance, contract, or operational update in the text.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

Insider sales can be tax- or diversification-driven; the article provides no context on motives, other holdings, or whether additional sales occurred around the same period.

Relevance 4/10Novelty 6/10Timing: filed 2026-06-15; sale executed 2026-06-12

Background

The article is an SEC Form 4 insider transaction disclosure for UFP Technologies (UFPT).

Company-level read

Ticker impact

$UFPTNeutralMedium confidence
Context

UFP Technologies director Cynthia L. Feldmann sold 1,200 shares in an open-market transaction at about $239.19–$240.40 on 2026-06-12.

Expected impact

Likely limited/short-lived impact; any effect would be sentiment-driven rather than a re-rating catalyst.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the transaction size is small relative to typical market cap and lacks accompanying operational or guidance changes.

Market effects

No sector-level read-through is provided; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing; the absence of a stated 10b5-1 plan does not by itself imply negative fundamentals.

Key entities

  • UFP Technologies Inc

    Company whose director filed the Form 4 insider sale disclosure.

  • Cynthia L. Feldmann

    Director who sold 1,200 shares of UFPT on 2026-06-12.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly